The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
1096917412 10969174 12 F 20150302 20160706 20150331 20160716 EXP JP-AMGEN-JPNNI2015029965 AMGEN 67.00 YR E M Y 56.00000 KG 20160715 MD JP JP

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
1096917412 10969174 1 PS panitumumab PANITUMUMAB 1 Intravenous drip 6 MG/KG, Q2WK 12 MG/KG Y Y 125147 6 MG/KG SOLUTION FOR INJECTION QOW
1096917412 10969174 2 SS panitumumab PANITUMUMAB 1 Intravenous drip 6 MG/KG, Q2WK 12 MG/KG Y Y 125147 6 MG/KG SOLUTION FOR INJECTION QOW
1096917412 10969174 3 SS panitumumab PANITUMUMAB 1 Intravenous drip 6 MG/KG, Q2WK 12 MG/KG Y Y 125147 6 MG/KG SOLUTION FOR INJECTION QOW
1096917412 10969174 4 SS panitumumab PANITUMUMAB 1 Intravenous drip 6 MG/KG, Q2WK 12 MG/KG Y Y 125147 6 MG/KG SOLUTION FOR INJECTION QOW
1096917412 10969174 5 SS OXALIPLATIN. OXALIPLATIN 1 Intravenous drip 85 MG/M2, Q2WEEKS 260 MG U 0 85 MG/M**2 QOW
1096917412 10969174 6 SS OXALIPLATIN. OXALIPLATIN 1 Intravenous drip 65 MG/M2, Q2WEEKS 260 MG U 0 65 MG/M**2 QOW
1096917412 10969174 7 SS OXALIPLATIN. OXALIPLATIN 1 Intravenous drip 65 MG/M2, Q2WEEKS 260 MG U 0 65 MG/M**2 QOW
1096917412 10969174 8 SS OXALIPLATIN. OXALIPLATIN 1 Intravenous drip 50 MG/M2, Q2WEEKS 260 MG U 0 50 MG/M**2 QOW
1096917412 10969174 9 SS 5-FU /00098801/ FLUOROURACIL 1 Intravenous bolus 400 MG/M2, Q2WK 5600 MG/M2 U 0 400 MG/M**2 QOW
1096917412 10969174 10 SS 5-FU /00098801/ FLUOROURACIL 1 Intravenous drip 2400 MG/M2, Q2WEEKS 5600 MG/M2 U 0 2400 MG/M**2 QOW
1096917412 10969174 11 SS 5-FU /00098801/ FLUOROURACIL 1 Intravenous bolus 200 MG/M2, Q2WK 5600 MG/M2 U 0 200 MG/M**2 QOW
1096917412 10969174 12 SS 5-FU /00098801/ FLUOROURACIL 1 Intravenous drip 2000 MG/M2, Q2WEEKS 5600 MG/M2 U 0 2000 MG/M**2 QOW
1096917412 10969174 13 SS 5-FU /00098801/ FLUOROURACIL 1 Intravenous bolus 200 MG/M2, Q2WK 5600 MG/M2 U 0 200 MG/M**2 QOW
1096917412 10969174 14 SS 5-FU /00098801/ FLUOROURACIL 1 Intravenous drip 2000 MG/M2, Q2WEEKS 5600 MG/M2 U 0 2000 MG/M**2 QOW
1096917412 10969174 15 SS 5-FU /00098801/ FLUOROURACIL 1 Intravenous drip 1600 MG/M2, Q2WEEKS 5600 MG/M2 U 0 1600 MG/M**2 QOW
1096917412 10969174 16 C CALCIUM LEVOFOLINATE LEVOLEUCOVORIN CALCIUM 1 Intravenous drip 200 MG/M2, Q2WEEKS 400 MG/M2 U 0 200 MG/M**2 QOW
1096917412 10969174 17 C CALCIUM LEVOFOLINATE LEVOLEUCOVORIN CALCIUM 1 Intravenous drip 200 MG/M2, Q2WEEKS 400 MG/M2 U 0 200 MG/M**2 QOW
1096917412 10969174 18 C CALCIUM LEVOFOLINATE LEVOLEUCOVORIN CALCIUM 1 Intravenous drip 200 MG/M2, Q2WEEKS 400 MG/M2 U 0 200 MG/M**2 QOW
1096917412 10969174 19 C CALCIUM LEVOFOLINATE LEVOLEUCOVORIN CALCIUM 1 Intravenous drip 200 MG/M2, Q2WEEKS 400 MG/M2 U 0 200 MG/M**2 QOW
1096917412 10969174 20 C PLAVIX CLOPIDOGREL BISULFATE 1 Oral UNK U 0
1096917412 10969174 21 C BUFFERIN /00009201/ ASPIRINDIHYDROXYALUMINUM AMINOACETATE ANHYDROUSMAGNESIUM CARBONATE 1 Oral UNK U 0

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
1096917412 10969174 1 Rectal cancer
1096917412 10969174 5 Rectal cancer
1096917412 10969174 9 Rectal cancer
1096917412 10969174 16 Rectal cancer
1096917412 10969174 20 Acute myocardial infarction
1096917412 10969174 21 Acute myocardial infarction

Outcome of event

Event ID CASEID OUTC COD
1096917412 10969174 OT
1096917412 10969174 HO

Reactions reported

Event ID CASEID DRUG REC ACT PT
1096917412 10969174 Dermatitis acneiform
1096917412 10969174 Dysgeusia
1096917412 10969174 Febrile neutropenia
1096917412 10969174 Neuropathy peripheral
1096917412 10969174 Neutrophil count decreased Neutrophil count decreased
1096917412 10969174 Paronychia
1096917412 10969174 Stomatitis

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
1096917412 10969174 1 20150217 20150302 0
1096917412 10969174 2 20150413 20150622 0
1096917412 10969174 3 20150713 20150810 0
1096917412 10969174 4 20150831 20151116 0
1096917412 10969174 5 20150217 20150302 0
1096917412 10969174 6 20150413 20150622 0
1096917412 10969174 7 20150713 20150810 0
1096917412 10969174 8 20150831 20151116 0
1096917412 10969174 9 20150217 20150302 0
1096917412 10969174 10 20150217 20150302 0
1096917412 10969174 11 20150413 20150622 0
1096917412 10969174 12 20150413 20150622 0
1096917412 10969174 13 20150713 20150810 0
1096917412 10969174 14 20150713 20150810 0
1096917412 10969174 15 20150831 20151116 0
1096917412 10969174 16 20150217 20150302 0
1096917412 10969174 17 20150413 20150622 0
1096917412 10969174 18 20150713 20150810 0
1096917412 10969174 19 20150831 20151116 0
1096917412 10969174 20 2009 20150326 0
1096917412 10969174 21 2009 20150326 0